BIOINFORMATICS TRAINING AND RESEARCH PROJECTS WITH PUBLICATION SUPPORT @ARAVINDABIO
Aravinda bios
WE ARE PROVIDING BIOINFORMATICS INDUSTRIAL TRAINING AND PROJECTS SINCE YEAR 2000.
Aravinda Bio invites applications for Industrial Training, Research/Academic Projects with Publication support and Guidance on BIOINFORMATICS, CHEMINFORMATICS, Molecular Modelling & Drug Designing (MMDD), Computer Aided Drug Designing (CADD), Fragment Based Drug Designing (FBDD), Docking Studies, 2D QSAR, 3D QSAR, HOMOLOGY MODELING, PERL, BIOPERL Programming in the Months of DEC-2013 & JAN, FEB, MARCH, APRIL, MAY, and JUNE 2014.
Interested candidates can register their names by email or phone call. Limited students in each batch. For more details just fill the enquiry form available in our website. Email: manoj...@aravindabio.com, enq...@aravindabio.com, aravi...@yahoo.com or call 09391187818 (Raghu Raj).
For more details Please visit our website: http://www.aravindabio.com.
Aravinda Biosolutions Pvt. Ltd.,
#311, Windsor Plaza,
Shankermutt, Nallakunta,
Hyderabad, Pin: 500 029
Andhra Pradesh, India.
Ph: 040-66628773
Mobile: 09391187818 (RAGHU RAJ)
PUBLICATION DETAILS OF OUR STUDENTS AND FACULTIES:
2. MOLECULAR DOCKING AND ADMET STUDY OF QUINOLINE-BASED DERIVATIVES FOR ANTI-CANCER ACTIVITY, Manoj Kumar Mahto, Khunza Meraj, Eftekhari K, Zeinab MN, Poojitha G, Bhaskar M. VRI Bioinformatics & Proteomics. 2013, 1(1), 1-8.
3. ADMET & MOLECULAR DOCKING STUDIES OF NOVEL ZANAMIVIR ANALOGS AS NEURAMINIDASE INHIBITORS. Manoj Kumar Mahto, V Likhitha Raj, Prof. M. Bhaskar, Divya.R. International Journal of Pharmaceutical Sciences Review and Research. 2012, 13(1), 91-94.
4. DEVELOPMENT OF BETTER ANALOGS OF VALPROIC ACID FOR THE TREATMENT OF EPILEPSY BY CADD. Manoj Kumar Mahto, Jaya Tripathi, Divya. R, Prof. M. Bhaskar. International Journal of Pharmaceutical Sciences and Drug Research. 2012, 4(1), 77-79.
5. INSILICO DESIGN AND DISCOVERY OF SOME NOVEL ACHE INHIBITORS FOR TREATMENT OF ALZHEIMER’S DISORDER. Sandeep Reddy Ch, Sree Kumar Reddy G, Manoj Kumar Mahto, Pavan Kunala, ChaitanyaKanth R. Research Journal of Pharmacy and Technology. 2012, 5 (3), 425-428.
6.MOLECULAR DOCKING AND TOXICITY ANALYSIS OF NOVEL ATORVASTATIN STRUCTURAL ANALOGUES WITH HMG-COA REDUCTASE, Jaya Tripathi, Manoj Kumar Mahto, Divya. R, Prof. M. Bhaskar, Sajad Shahbazi. Asian Journal of Research in Chemistry. 2012, 5(3), 386-389.
7. COMPARATIVE DOCKING STUDIES OF ESTROGEN RECEPTOR INHIBITORS AND THEIR BINDING INTERACTION ANALYSIS, Nidhi Desai, Manoj Kumar Mahto, B. Alekhya, C.R.Naveen, Prof. M.Bhaskar. International Journal of Pharmaceutical Sciences Review and Research. 2012, 16(1), 91-95.
8.DOCKING ANALYSIS, ADME AND TOXICITY PROFILES OF INDAZOLE PYRIDINE BASED PROTEIN AKT INHIBITORS, N Blessy Christina, Manoj Kumar Mahto, Khunza Meraj, Prof. M Bhaskar. International Journal of Pharmaceutical Sciences Review and Research. 2012, 17(2), 56-61.
9. PHARMACOPHORE MODELLING, 3D-QSAR STUDY AND DOCKING OF NAPHTHOL DERIVATIVES AS B-RAF(V600E) RECEPTOR ANTAGONISTS, Khunza Meraj, K. Kiran Kumar, , Mohamed Sidig, Azam Soltany, P. Anugnya Reddy, Manoj Kumar Mahto, M Bhaskar. VRI Bioinformatics & Proteomics. 2013, 1(1), 18-29.
10. ANALOGS OF CARBIDOPA: INSILICO DESIGN & DEVELOPMENT OF NOVEL DOPA DECARBOXYLASE INHIBITORS IN THE TREATMENT OF PARKINSON’S DISEASE. M Lakshmi Vasavi Devi, Deepak Reddy Gade, T Gopi Raju, Pavan Kunala. Journal of Pharmaceutical Sciences & Research. 2011, 3(4), 1176-1181.
11. 3D QSAR AND PHARMACOPHORE IDENTIFICATION OF ISOQUINOLINE AND BENZIMIDAZOLE ANALOGS AS POTENT C-RAF INHIBITORS. Blessy Christina N, Manoj Kumar Mahto, Uday kumar Dasari, M Bhaskar. International Journal of Bioassays. 2013, 02(10), 1327-1332.